Analysis of myosmine, cotinine and nicotine in human toenail, plasma and saliva

Biomarkers

Volumn 14, Issue 5, 2009, Pages 278-284

  Schtte Borkovec, Katharina ^a   Heppel, Christopher W ^a   Heling, Anne Kathrin ^a   Richter, Elmar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cotinine; Myosmine; Nicotine; Plasma; Saliva; Toenail

Indexed keywords

ALKALOID DERIVATIVE; COTININE; MYOSMINE; NICOTINE; UNCLASSIFIED DRUG; ALKALOID;

ARTICLE; BIOLOGICAL MONITORING; BLOOD LEVEL; CHEMICAL STRUCTURE; CIGARETTE SMOKING; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN EXPERIMENT; MASS FRAGMENTOGRAPHY; NAIL; SALIVA LEVEL; VALIDATION STUDY; ANIMAL; CATTLE; CHEMISTRY; ESOPHAGOSCOPY; FEMALE; MALE; METHODOLOGY; SALIVA; SMOKE; TOBACCO;

NICOTIANA TABACUM;

ALKALOIDS; ANIMALS; CATTLE; COTININE; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGOSCOPY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MOLECULAR STRUCTURE; NAILS; NICOTINE; SALIVA; SMOKE; TOBACCO;

EID: 70149089689     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500902898164     Document Type: Article

References (49)

1. Al-Delaimy WK, Mahoney GN, Speizer FE, Willett WC. (2002). Toenail nicotine levels as a biomarker of tobacco smoke exposure. Cancer Epidemiol Biomarkers Prev 11:1400-1404
2. Al-Delaimy WK, Stampfer MJ, Manson JE, Willett WC. (2008). Toenail nicotine levels as predictors of coronary heart disease among women. Am J Epidemiol 167:1342-1348
3. Al-Delaimy WK, Willett WC. (2008). Measurement of tobacco smoke exposure: comparison of toenail nicotine biomarkers and selfreports. Cancer Epidemiol Biomarkers Prev 17:1255-1261
4. Anon. (1994). DIN 32 645: Chemische Analytik; Nachweis-, Erfassungs- und Bestimmungsgrenze; Ermittlung unter Wiederholbedingungen; Begriffe, Verfahren, Auswertung. Berlin, Germany: Beuth Verlag.
5. Atawodi SE, Lea S, Nyberg F, Mukeria A, Constantinescu V, Ahrens W, Brueske-Hohlfeld I, Fortes C, Boffetta P, Friesen MD. (1998). 4-Hydroxy-1-(3-pyridyl)-1-butanone-hemoglobin adducts as biomarkers of exposure to tobacco smoke: validation of a method to be used in multicenter studies. Cancer Epidemiol Biomarkers Prev 7:817-821
6. Baker RR. (1999). Smoke chemistry. In: Davis DL, Nielsen MT, editors. Tobacco Production, Chemistry and Technology. Oxford: Blackwell Science Ltd. p. 398-439.
7. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. (2001). Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92:549-555
8. Branner B, Kutzer C, Zwickenpflug W, Scherer G, Heller WD, Richter E. (1998). Haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and nonsmoking women. Biomarkers 3:35-47.
9. Carmella SG, Kagan SS, Kagan M, Foiles PG, Palladino G, Quart AM, Quart E, Hecht SS. (1990). Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuffdippers, smokers, and non-smokers. Cancer Res 50:5438-5445
10. Cook MB, Wild CP, Forman D. (2005). A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 162:1050-1061
11. Dempsey D, Tutka P, Jacob P, Allen F, Schoedel K, Tyndale RF, Benowitz NL. (2004). Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 76:64-72.
12. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. (2007). Central adiposity and risk of Barrett's esophagus. Gastroenterology 133:403-411
13. Falter B, Kutzer C, Richter E. (1994). Biomonitoring of hemoglobin adducts: Aromatic amines and tobacco-specific nitrosamines. Clin Invest 72:364-371
14. Glas S, Tyroller S, Zwickenpflug W, Steiner K, Kiefer G, Richter E. (2007). Tissue distribution and excretion of myosmine after i.v. administration to Long-Evans rats using quantitative wholebody autoradiography. Arch Toxicol 81:151-161
15. Halim AF, Collins RP, Berigari MS. (1971). Alkaloids produced by Cestrum nocturnum and Cestrum diurnum. Plant Med 20:44-49
16. Havla JB, Hill CE, Abdel-Rahman SZ, Richter E. (2009). Evaluation of the mutagenic effects of myosmine in human lymphozytes using the HPRT gene mutation assay. Food Chem Toxicol 47:237-241
17. Hecht SS. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559-603.
18. Hecht SS. (2003). Tobacco carcinogens, their biomarkers and tobaccoinduced cancer. Nat Rev Cancer 3:733-744
19. Heppel CW, Heling A-K, Richter E. (2009). Ultrasensitive method for the determination of 4-hydroxy-1-(3-pyridyl)-1-butanonereleasing DNA adducts by gas chromatography-high resolution mass spectrometry in mucosal biopsies of the lower esophagus. Anal Bioanal Chem 393:1525-1530
20. Hölzle D, Schlöbe D, Tricker AR, Richter E. (2007). Mass spectrometric analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in human lung. Toxicology 232:277-285
21. Hukkanen J, Jacob P, Benowitz NL. (2005). Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57:79-115.
22. IARC. (2007). Smokeless tobacco and tobacco-specific nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol.89. Lyon, France: IARC.
23. Iijima K, Grant J, McElroy K, Fyfe V, Preston T, McColl KEL. (2003). Novel mechanism of nitrosative stress from dietary nitrate with relevance to gastro-oesophageal junction cancers. Carcinogenesis 24:1951-1960
24. Kleinsasser NH, Wallner BC, Harréus UA, Zwickenpflug W, Richter E. (2003). Genotoxic effects of myosmine in human lymphocytes and upper aerodigestive tract epithelial cells. Toxicology 192:171-177
25. Kuroiwa Y, Okamura T, Ishii Y, Umemura T, Tasaki M, Kanki K, Mitsumori K, Hirose M, Nishikawa A. (2008). Enhancement of esophageal carcinogenesis in acid reflux model rats treated with ascorbic acid and sodium nitrite in combination with or without initiation. Cancer Sci 99:7-13.
26. Kyerematen GA, Taylor LH, deBéthizy JD, Vesell ES. (1988). Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay. Drug Metab Dispos 16:125-129
27. Luanratana O, Griffin WJ. (1982). Alkaloids of Duboisia hopwoodii. Phytochem Oxford 21:449-451
28. Maier M. (2005). Biomonitoring der Myosminbelastung des Menschen in Muttermilch, Speichel und Plasma. Dissertation an der Medizinischen Fakultät der LMU.
29. Maier M, Schulze A, Richter E. (2005). Biomonitoring of myosmine in human milk and saliva. Toxicol Lett 158:S201-2.
30. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD. (2002). Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem 48:1460-1471
31. Nelson PR, Kelly SP, Conrad FW. (1998). Studies of environmental tobacco smoke generated by different cigarettes. J Air Waste Manage Assoc 48:336-344
32. Palmeri A, Pichini S, Pacifici R, Zuccaro P, Lopez A. (2000). Drugs in nails: Physiology, pharmacokinetics and forensic toxicology. Clin Pharmacokinet 38:95-110.
33. Richter E, Schlöbe D, Hölzle D, Wilp J. (2002). Comparative DNA and hemoglobin adduct formation by dietary myosmine and N'-nitrosonornicotine in rats. Naunyn Schmiedebergs Arch Pharmacol 365 (Suppl. 1):R140.
34. Richter E, Wilson S, Kahn RS, Lanphear BP. (2007). Differences in cotinine in tobacco-exposed children. Chest 132:1716-1717
35. Schlöbe D, Hölzle D, Hatz D, von Meyer L, Tricker AR, Richter E. (2008). 4-Hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in lung, lower esophagus and cardia of sudden death victims. Toxicology 245:154-161
36. Smalberger TM, Rall GJH, de Waal HL. (1968). Carica papaya alkaloids. Tydsk Natuurwetenskappe 8:156-157
37. Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS. (2006). Mass spectrometric quantitation of nicotine, cotinine, and 4-(methyinitrosamino)-1- (3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomarkers Prev 15:2378-2383
38. Stepanov I, Hecht SS. (2008). Detection and quantitation of N'- nitrosonornicotine in human toenails by liquid chromatography- electrospray ionization-tandem mass spectrometry. Cancer Epidemiol Biomarkers Prev 17:945-948
39. Stepanov I, Hecht SS, Lindgren B, Jacob P, Wilson M, Benowitz NL. (2007). Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine. Cancer Epidemiol Biomarkers Prev 16:1382-1386
40. Terasaki M, Totsuka Y, Nishimura K, Mukaisho K-I, Chen K-H, Hattori T, Takamura-Enya T, Sugimura T, Wakabayashi K. (2008). Detection of endogenous DNA adducts, O6-carboxymethyl-2'- deoxyguanosine and 3-ethanesulfonic acid-2'-deoxycytidine, in the rat stomach after duodenal reflux. Cancer Sci 99:1741-1746
41. Tricker AR. (2006). Biomarkers derived from nicotine and its metabolites: A review. Contrib Tobacco Res 22:147-175
42. Tyroller S, Zwickenpflug W, Richter E. (2002). New sources of dietary myosmine uptake from cereals, fruits, vegetables and milk. J Agric Food Chem 50:4909-4915
43. Vogt S, Fuchs K, Richter E. (2006). Genotoxic effects of myosmine in a human esophageal adenocarcinoma cell line. Toxicology 222:71-79
44. Wenusch A, Schöller R. (1933). Beitrag zur Kenntnis der Zusammensetzung des Zigarrenrauches. Fachliche Mitteilungen der Österreichischen Tabakregie 2:15-19.
45. Wilp J, Zwickenpflug W, Richter E. (2002). Nitrosation of dietary myosmine as risk factor of human cancer. Food Chem Toxicol 40:1223-1228
46. Zwickenpflug W. (2000). N-nitrosation of myosmine yields HPB (4-hydroxy-1-(3-pyridyl)-1-butanone) and NNN (N-nitrosonornicotine). J Agric Food Chem 48:392-394
47. Zwickenpflug W, Meger M, Richter E. (1998). Occurrence of the tobacco alkaloid myosmine in nuts and nut products of Arachus hypogaea and Corylus avellana. J Agric Food Chem 46:2703-2706
48. Zwickenpflug W, Tyroller S. (2006). Reaction of the tobacco alkaloid myosmine with hydrogen peroxide. Chem Res Toxicol 19:150-155
49. Zwickenpflug W, Tyroller S, Richter E. (2005). Metabolism of myosmine in Wistar rats. Drug Metab Dispos 33:1648-1656